JBNI Releases All-Natural All-Herbal Bioprin Anti-Tumor Report...

There are 1 comment on the PRWeb story from Jun 30, 2008, titled JBNI Releases All-Natural All-Herbal Bioprin Anti-Tumor Report.... In it, PRWeb reports that:

- Today, JBNI Inc. released a TSRA lab report documenting Bioprin's anti-tumor activity against invivo EMT-6 metastatic cancer cells. The study was conducted on Bioprin, Code named JJ 15.3, by members of top cancer pharmacology research facilities UCSD and Dana-Farber Cancer Institute/Harvard Medical School (DFCI/HMS) including Dr. Beverly Teicher. It found that while the Bioprin formula was already commercially available as an anti-inflamatory and all natural pain reliever, it showed greatest effectiveness against cancer cells when paired with FDA approved chemotherapeutic agents.Dr. Marianne Spada PhD's summary of the TSRA anti-tumor activity report notes that Bioprin's formula is, 'much more potent than Melphalan (2.3 TGD) or Carmustine (2.5 TGD) (commonly used chemotherapy agents).' She continues to report on Dr. Teicher's findings, '(Bioprin is) comparable to radiotherapy (4.3 TGD) or Cysplatin (6.2 TGD) in treatment of metasatic cancer...without burdening the GI tract. There are no signs of toxicity with this herbal mixture.'Inspite of the above findings on Bioprin's all natural formula that uses purely herbal incredients, JBNI strictly advises against using Bioprin without FDA approved clinical substances while under the care of a Board Certified Physician. A JBNI PR representative, Azim Walli states, 'anti-tumor efficacy, even under invivo conditions, cannot replace the expertise and experience of a trained cancer specialist's supervision of time tested FDA approved drugs.'The report reinforces JBNI's usage warning by documenting the efficacy of combining radiation therapy (1 wk at 300 rads - 4.3 TGD) together with Bioprin (4.15 TGD). The combined anti-tumor effect is documented at 5.41+-0.61 TGD.Talia Malka, LAc, in PA explains, 'because of the all-natural all-herbal formulation of Bioprin and it's anti-inflamatory pain killer properties, when Bioprin is used as a complementary naturaceutical to FDA approved drugs, Bioprin supports the body's ability to naturally manage the toxicity of powerful drugs and increases the user's tolerance against any harsh side effects. What you are left with is that Bioprin consumers can tolerate more aggressive treatments with minimal side effects. Ultimately they are shortening their treatment time and accelerating their time to remission.'When asked why this report conducted in 1995 was only now being released, JBNI operations director Ken Case explained, 'The last 15 years gave the JBNI team substantial time for clinical observations. Until now, we only distributed Bioprin to licensed physicians and health care professionals. We listened to what they had to say. After weighing out the cumulative data from the last decade and a half, JBNI can now responsibly release Bioprin to the public for commercial consumption as a nutritional suppliment or naturaceutical.'EMT-6/Parent tumor is equivalent to human metastatic breast cancer.Reluctantly, JBNI did admit that inspite of their warning against usage of Bioprin for animal cancer, over the years, veterinarians have increasingly reported favorable results doing just that. In response, JBNI is now pursuing official veterinary drug approval process for use of Bioprin on animal cancer. The JBNI investor relations department issued this statement, 'After 16 years of clinical observation and real world efficacy, interested parties are welcome to contact the IR department. Pursuing official status as an approved animal cancer drug is much less financially burdensome to JBNI than pursuing human clinical trials and human FDA drug approval.'Information regarding the use of Bioprin on animals is at http://www.jbni.us/dogs.html while the full TSRA JJ 15.3 anti-tumor activity report is available at http://dog-cancer.blogspot.com for public viewing.TSRA was a commercial biotech consulting firm and research laboratory with top biotechnology experts from Dana-Farber Cancer Institute / Harvard Medical School DFCI/HMS and UCSD. TSRA was actively studying all-natural anti-tumor treatments for metastatic cancer in the mid to late 1990's.###Media Contact:JBNI Biodrux Inc.Azim Walli(425) 408-9091Trackback URL: http://prweb.com/pingpr.php/RW1wdC1Db3VwLU1hZ24tWmV0YS1Qcm9mLVplcm8=

Join the discussion below, or Read more at PRWeb.

mary

Seattle, WA

#1 Jul 1, 2008
this sounds amazing!

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Pharmacology Discussions

Title Updated Last By Comments
On binding plasma proteins... Apr '15 helenabertoncini 1
News Where to buy dichloroacetate... (Jul '07) Jan '15 Grace Caine 47
steady state of a drug...can you please help me... (Sep '14) Sep '14 lhemz 1
steady state/i really need an answer for this. (Sep '14) Sep '14 lhemz 1
Metabolism of tertiary alcohol (Jul '14) Jul '14 intrnd711 1
News Oregon Medical Marijuana Doctor Answers All (Apr '07) May '14 dreed 109
Pharmacology of Effexor XR? (Jun '13) Nov '13 Hello 3
More from around the web